Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Surgical intervention in obesity
- Bariatric surgery and microbe-host interaction
- Bariatric surgery in non-obese rats
- Metabolic and microbial changes
- Roux-en-Y gastric bypass - summary
- Metabolic surgery and cancer
- Determination of the relative suspension growth
- O-PLS regression analyses of fecal water & urine
- miRNA of plasma from RYGB vs. Sham
- Predicted pathways - miRNAs
- miR122 analysis in RYGB vs. sham
- Modulation of hepatic metabolic activity
- Inflammation and cancer
- Targeted profiling of inflammation
- The early life environment shapes the microbiome
- Preterm birth and increased disease risk
- Metabolic signature of being born preterm
- Pattern of urinary bile acid profile in preterm infants
- Pharmacometabonomics
- Pharmaco-metabonomic drug metabolism in man
- Acetaminophen and 4-cresol structural analogues
- Cancer patient stratification
- Concluding remarks
- Acknowledgements
Topics Covered
- Surgical intervention in obesity
- Bariatric surgery and microbe-host interaction
- Metabolic surgery and cancer
- Predicted pathways – miRNAs
- miR122 analysis in RYGB vs. sham
- Inflammation and cancer
- Targeted profiling of inflammation
- The early life environment shapes the microbiome
- Preterm birth and increased disease risk
- Pharmacometabonomics
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Holmes, E. (2016, January 31). Metabolic communication in development and control of obesity 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/QPDD3607.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Elaine Holmes has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Metabolic communication in development and control of obesity 2
Published on January 31, 2016
25 min
Other Talks in the Series: Obesity: Science, Medicine and Society
Transcript
Please wait while the transcript is being prepared...
0:05
One of the most
effective cures for obesity
or means of tackling obesity
is surgical intervention.
Unfortunately, a low diet are
effective for some individuals,
the statistics show
that most individuals
achieve only a temporary effect
in terms of
sustained weight loss
with dietary intervention.
Gastric bypass on the other hand
has been shown to have
a much longer lasting effect.
There are several
studies that have looked
at the effect of gastric
bypass on the stomach
and intestine microbiota.
We know that gastric
bypass achieves
substantial and
significant weight loss.
We also know that
the microbiota change
after gastric bypass surgery.
So now we really want to
look at the relationship
between the gut bacteria,
the metabolic profile,
and see if we can look
at the mechanism
by which gastric bypass surgery
might be achieving weight loss.
1:06
The first port of call
was a surgical model
of gastric bypass.
And this was the Roux-en-Y
gastric bypass,
which is used in the U.K.,
for morbidly obese individuals.
In the U.K., you'd have to
have a BMI of greater than 40
or have some
significant comorbidities
at a lower BMI
to be eligible for
this type of surgery.
We know that in many cases,
as well as
achieving weight loss,
the gastric bypass
surgery also cures
or resolves type 2 diabetes
and this happens in about
80 percent of the cases.
In other countries
around the world,
they use gastric bypass surgery
almost cosmetically,
so if you're prepared to pay,
then you can go
and get gastric bypass surgery.
So it's becoming increasingly
prevalent all over the world,
and we really
do need to understand
what are the mechanisms
by which the weight loss occurs
and what are
the knock-on effects
metabolically on the individual.
So here we had
two groups of rats,
one was sham-operated in
order to induce surgical stress
as a control.
The other group underwent
Roux-en-Y gastric bypass,
18 animals per group,
and we looked at them
pre-operatively and up to
8 weeks post-operation.
We took urine, serum,
and feces from these animals
and then conducted
both metabolic profiling
and also looked at
the 454 sequencing
to establish
the microbial composition.